Fate shareholder alert: jakubowitz law reminds fate shareholders of a lead plaintiff deadline of march 22, 2023

New york , march 3, 2023 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of fate therapeutics, inc. (nasdaq: fate). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/fate-therapeutics-loss-submission-form/?id=36967&from=4 the lawsuit seeks to recover losses for shareholders who purchased fate between april 2, 2020 and january 5, 2023.
FATE Ratings Summary
FATE Quant Ranking